RADNOR, Pennsylvania, Sept. 25, 2017 /PRNewswire/ -- VWR (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, celebrated the opening of its new kitting center in Skalice, Czech Republic. This new facility will support the growing business of Therapak, which VWR acquired in 2016, by expanding its existing footprint in Europe with a state of the art facility and comprehensive kitting services for regional and global customers.

VWR celebrates opening of new Kitting Center in Czech Republic (L-R: VWR team Jitka Neuzilova, Ulf Kepper, Vaclava Moravcova, Todd Gates, Martina Novakova, Charlie Daniels and Petr Moravec)

"VWR's Czech Republic facility is strategically located to support customers in the EMEA region for all their clinical and commercial kitting needs," said Ulf Kepper, SVP, Services for VWR. "This location expands our VWRCATALYST offering to support the growing demand for quality services to the industries we support."

The 35,000-square foot facility will be fully operational on October 2, 2017, and is in proximity to major industrial freight carrier hubs, which is ideal for shipping and will allow enhanced service levels compared to VWR's current model.

Therapak, a leading supplier of pre-packaged convenience kits and procedure packs for the clinical trial, pharmaceutical and clinical laboratory industries, has proven to be a valued addition to the VWRCATALYST Clinical and Biorepository Services.

Along with the recent acquisitions of MESM and EPL Archives, VWRCATALYST Clinical and Biorepository Services offers a complete solution to its global regulated research and product development clients in the pharma, biopharma, manufacturing and clinical trial industries. Our focus is to eliminate the process complexities and identify service solutions that help labs and production facilities work better, faster, and smarter.  

About VWR 
VWR (NASDAQ: VWR), headquartered in Radnor, Pennsylvania, is the leading global independent provider of product and service solutions to laboratory and production customers. With sales in excess of $4.5 billion in 2016, VWR enables science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. With more than 160 years of experience, VWR has cultivated a value proposition delivering product choice, operational excellence and differentiated services to improve our customers' productivity from research to production. VWR's differentiated services provide innovative, flexible and customized solutions from scientific research services to custom-manufactured chemical blends. Our dedicated team of more than 10,200 associates is focused on supporting scientists, medical professionals and production engineers to achieve their goals.

For more information on VWR please visit www.vwr.com.

Media Contact:
Valerie Collado
Director, Corporate Communications
VWR 
484.885.9338
Valerie_collado@vwr.com

VWR International, LLC Logo.

Photo - http://mma.prnewswire.com/media/560515/VWR_Czech_Republic_Kitting_Center_Ribbon_Cutting.jpg
Logo - http://mma.prnewswire.com/media/95343/vwr_international__llc_logo.jpg

Copyright 2017 PR Newswire

VWR CORP (NASDAQ:VWR)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more VWR CORP Charts.
VWR CORP (NASDAQ:VWR)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more VWR CORP Charts.